The efficacy and safety profile of lisdexamfetamine dimesylate, a prodrug of d-amphetamine, for the treatment of attention-deficit/hyperactivity disorder in children and adults

Attention Deficit ◽

Safety Profile ◽

Efficacy And Safety ◽

Efficacy and Safety of Lisdexamfetamine Dimesylate and Atomoxetine in the Treatment of Attention-Deficit/Hyperactivity Disorder: a Head-to-Head, Randomized, Double-Blind, Phase IIIb Study

CNS Drugs ◽

10.1007/s40263-013-0104-8 ◽

2013 ◽

Vol 27 (12) ◽

pp. 1081-1092 ◽

Cited By ~ 53

Author(s):

Ralf W. Dittmann ◽

Esther Cardo ◽

Peter Nagy ◽

Colleen S. Anderson ◽

Ralph Bloomfield ◽

...

Keyword(s):

Attention Deficit ◽

Efficacy And Safety ◽

Double Blind ◽

Hyperactivity Disorder ◽

Phase Iiib

Lisdexamfetamine dimesylate in the treatment of attention-deficit/hyperactivity disorder: pharmacokinetics, efficacy and safety in children and adolescents

Archives of Clinical Psychiatry (São Paulo) ◽

10.1590/0101-60830000000007 ◽

2014 ◽

Vol 41 (2) ◽

pp. 34-39 ◽

Cited By ~ 2

Author(s):

Paulo Mattos

Keyword(s):

Children And Adolescents ◽

Attention Deficit ◽

Efficacy And Safety ◽

Efficacy and Safety of Lisdexamfetamine Dimesylate in Adolescents With Attention-Deficit/Hyperactivity Disorder

Journal of the American Academy of Child & Adolescent Psychiatry ◽

10.1016/j.jaac.2011.01.007 ◽

2011 ◽

Vol 50 (4) ◽

pp. 395-405 ◽

Cited By ~ 72

Author(s):

Robert L. Findling ◽

Ann C. Childress ◽

Andrew J. Cutler ◽

Maria Gasior ◽

Mohamed Hamdani ◽

...

Keyword(s):

Attention Deficit ◽

Efficacy And Safety ◽

Efficacy and Safety of Lisdexamfetamine Dimesylate [LDX; NRP104] in Children Aged 6 to 12 Years with Attention-Deficit/Hyperactivity Disorder

Journal of Developmental & Behavioral Pediatrics ◽

10.1097/00004703-200610000-00057 ◽

2006 ◽

Vol 27 (5) ◽

pp. 443 ◽

Cited By ~ 2

Author(s):

Joseph Biederman ◽

Hilary Mandler ◽

Suma Krishnan ◽

Robert L. Findling

Keyword(s):

Attention Deficit ◽

Efficacy And Safety ◽

Randomized, double-blind, placebo-controlled, crossover study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: novel findings using a simulated adult workplace environment design

Behavioral and Brain Functions ◽

10.1186/1744-9081-6-34 ◽

2010 ◽

Vol 6 (1) ◽

pp. 34 ◽

Cited By ~ 86

Author(s):

Timothy Wigal ◽

Matthew Brams ◽

Maria Gasior ◽

Joseph Gao ◽

Liza Squires ◽

...

Keyword(s):

Crossover Study ◽

Attention Deficit ◽

Environment Design ◽

Efficacy And Safety ◽

Double Blind ◽

Workplace Environment ◽

Double Blind Placebo ◽

Efficacy and Safety of Lisdexamfetamine Dimesylate in Children with Attention-Deficit/Hyperactivity Disorder and Recent Methylphenidate Use

Advances in Therapy ◽

10.1007/s12325-013-0027-2 ◽

2013 ◽

Vol 30 (5) ◽

pp. 472-486 ◽

Cited By ~ 3

Author(s):

Rakesh Jain ◽

Thomas Babcock ◽

Teodor Burtea ◽

Bryan Dirks ◽

Ben Adeyi ◽

...

Keyword(s):

Attention Deficit ◽

Efficacy And Safety ◽

Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder

The Journal of Clinical Psychiatry ◽

10.4088/jcp.v69n0903 ◽

2008 ◽

Vol 69 (9) ◽

pp. 1364-1373 ◽

Cited By ~ 140

Author(s):

Lenard A. Adler ◽

David W. Goodman ◽

Scott H. Kollins ◽

Richard H. Weisler ◽

Suma Krishnan ◽

...

Keyword(s):

Attention Deficit ◽

Controlled Study ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Efficacy and Safety of Lisdexamfetamine Dimesylate in Adolescents With Attention-Deficit/Hyperactivity Disorder

Yearbook of Psychiatry and Applied Mental Health ◽

10.1016/j.ypsy.2011.08.095 ◽

2012 ◽

Vol 2012 ◽

pp. 51-53

Author(s):

A.H. Mack

Keyword(s):

Attention Deficit ◽

Efficacy And Safety ◽

Efficacy and safety of saffron as adjunctive therapy in adults with attention-deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled clinical trial

Advances in Integrative Medicine ◽

10.1016/j.aimed.2022.01.002 ◽

2022 ◽

Author(s):

Benyamin Pazoki ◽

Nadia Zandi ◽

Zeinab Assaf ◽

Hossein Sanjari Moghaddam ◽

Arefeh Zeinoddini ◽

...

Keyword(s):

Clinical Trial ◽

Attention Deficit ◽

Adjunctive Therapy ◽

Controlled Clinical Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Adverse Events in Medication Treatment-Naïve Children with Attention-Deficit/Hyperactivity Disorder: Results from a Small, Controlled Trial of Lisdexamfetamine Dimesylate

Journal of Child and Adolescent Psychopharmacology ◽

10.1089/cap.2010.0095 ◽

2012 ◽

Vol 22 (2) ◽

pp. 149-156 ◽

Cited By ~ 12

Author(s):

Sharon B. Wigal ◽

Amanda A. Wong ◽

Angela Jun ◽

Annamarie Stehli ◽

Robin Steinberg-Epstein ◽

...

Keyword(s):

Adverse Events ◽

Attention Deficit ◽

Controlled Trial ◽

Medication Treatment ◽

Hyperactivity Disorder ◽

Treatment Naïve